期刊文献+

视网膜光凝术治疗对Eales病患者血浆内皮素-1水平的影响 被引量:1

Effect of laser photocoagulation on plasma endothelin-1 levels in patients with Eales′ disease
暂未订购
导出
摘要 目的探讨视网膜静脉周围炎(又称Eales病)患者视网膜光凝术治疗前后血浆内皮缩血管肽-1(又称内皮素-1,ET-1)水平的变化。方法对104例Eales病患者和66例健康者进行血浆ET-1水平检测。对53例Eales病患者进行视网膜光凝术治疗,并分别于激光治疗前及治疗后1个月进行血浆内皮素-1检测。结果 Eales病患者血浆ET-1水平为(23.10±6.89)pg/mL,健康者血浆ET-1水平为(17.79±5.02)pg/mL,前者ET-1水平高于后者,比较差异有统计学意义(P<0.05)。53例Eales病患者光凝术治疗前血浆ET-1水平为(22.98±6.88)pg/mL,术后1个月为(20.17±6.48)pg/mL,治疗后ET-1水平显著降低,治疗前后比较差异有统计学意义(P<0.05)。结论 Eales病患者血浆ET-1水平增高,视网膜光凝术治疗后1个月ET-1水平显著下降。 Objective To explore the changes of plasma endothelin-1 (ET-1)level in patients with Eales′dis-ease before and after laser photocoagulation.Methods Plasma levels of ET-1 were detected in 104 patients with Eales′disease and 66 cases of healthy subjects.53 patients with Eales′disease were treated with laser photocoagula-tion,and detected for plasma levels of ET-1 before and one month after operation.Results The plasma level of ET-1 in patients with Eales′disease were (23.10&#177;6.89)pg/mL,which was significantly higher than the (17.79&#177;5.02) pg/mL in healthy subjects (P&lt;0.05).The plasma level of ET-1 in patents with Eales′disease,detected before oper-ation was (22.98&#177;6.88)pg/mL,which was significantly higher than the (20.17&#177;6.48)pg/mL,detected one month after operation (P&lt;0.05).Conclusion The plasma level of ET-1 in patients with Eales′disease might be increased, which could be significantly decreased one month after laser treatment.
出处 《检验医学与临床》 CAS 2014年第4期438-440,共3页 Laboratory Medicine and Clinic
基金 河北省沧州市科技局科学技术研究与发展指导计划项目(09ZD50)
关键词 视网膜静脉周围炎 内皮素-1 激光凝固术 ENDOTHELIN-1 retinal periphlebitis laser coagulation
  • 相关文献

参考文献13

二级参考文献79

  • 1俞学斌,金国良,丁建仁,王晓明,李锦泉.急性颅脑创伤患者IL-6,TNFa含量的变化及其临床意义[J].中华神经外科杂志,2004,20(4):346-346. 被引量:11
  • 2王润生.前部缺血性视神经病变发病机理探讨[J].中国实用眼科杂志,1995,13(12):754-756. 被引量:20
  • 3全国眼底病协作组.糖尿病性视网膜病变分期标准[J].中华眼科杂志,1985,21:113-113.
  • 4严宏 张东杲 等.内皮素Ⅰ型对豚鼠视网膜组织cAMP和cGMP的影响[J].中华眼底病杂志,1995,11:63-63.
  • 5Sulochana KN,Ramakrishnan S,Rajesh M,Coral K,Badrinath SS.Diabetic retinopathy:molecular mechanisms,present regime of treatment and future prospectives.Curr Sci 2001;80(2):133-142.
  • 6Klein R,Klein BE,Moss SE,Davis MD,DeMets DL.The Wisconsin epidemiologic study of diabetic retinopathy.Ⅲ.Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.Arch Ophthalmol 1984;102(4):527-532.
  • 7Caine GJ,Blann AD,Stonelake PS,Ryan P,Lip GY.Plasma angiopoietin-1,angiopoietin-2 and Tie-2 in breast and prostate cancer:a comparison with VEGF and Flt-1.Eur J Clin Invest 2003;33(10):883-890.
  • 8Aeillo LP,Avery RL,Arigg PG,Keyt BA,Jampel HD,Shah ST,Pasguale LR,Thieme H,Iwamoto MA Park SE.Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders.N Engl J Med 1994;331(22):1480-1487.
  • 9Marsden PA,Heng HH,Scherer SW,Stewart RJ,Hall AV,Shi XM,Tsui LC,Schappert KT.Structure and chromosomal localization of the human constitutive endothelial ntric oxide synthase gene.J Biol Chem 1993;268(23):17478-17488.
  • 10Li H,Forstermann U.Nitric oxide in the pathogenesis of vascular disease.J Pathol 2000;190(3):244-254.

共引文献70

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部